Tirzepatide and semaglutide GLP-1 are both effective medications for weight loss, but their effectiveness and suitability can vary depending on individual health needs and goals
3.3 Long-acting GLP1 receptor agonists: Once-weekly 3.3.1 Semaglutide SMG is an analog of long-acting GLP-1, mainly used to control T2DM, and is also suitable for promoting weight loss in people with mild obesity (95, 96)
Some ways to manage common side effects might include: Starting at the lowest possible dose and gradually increasing it over time Taking prescription or over-the-counter anti-nausea medications Eating smaller, more frequent meals Drinking plenty of water Warnings and precautions Serious adverse effects are rare but have been reported with semaglutide
A physician-supervised plan can help answer whether the medication is appropriate, which option fits the patients risk profile, what dose should be used, how quickly the dose should increase, what side effects should be expected, when the dose should be held or adjusted, how much protein the patient should eat, how muscle can be preserved, what labs should be tracked, and what long-term maintenance should look like
Many insurers require current BMI documentation, weight history, medical records, obesity-related diagnoses, prior authorization forms, and evidence of previous weight loss attempts
